WEST PHARMACEUTICAL SERVICES INC (WST) Options Risk Score

Run a full WST options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on WEST PHARMACEUTICAL SERVICES INC (WST) right now?

For a 4-week expiry, WEST PHARMACEUTICAL SERVICES INC (WST) carries an options catalyst-risk score of 100 out of 100 (HIGH). That score is driven by an upcoming earnings report, 16 recent news items, 3 active legal filings and 77 clinical-trial catalysts falling inside the 4-week window. A HIGH reading (70+) means WST has a dated event inside the window, so an option sold here carries gap risk that time decay alone will not pay for. The score ranks event exposure, not the likely direction of the move.

WST shows an IV Rank of 62, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 42%. IV Rank answers how WST options are priced against their own history, which is the starting point for choosing between selling and buying premium.

WST is scheduled to report earnings on 2026-10-29, which falls inside a typical monthly options expiry — expect elevated implied volatility into the event and an IV crush afterward.

WEST PHARMACEUTICAL SERVICES INC (WST) current implied volatility and IV Rank

WST's IV Rank stands at 62 right now with implied volatility around 42%, alongside a TickerRisk options-risk score of 100/100. That is roughly mid-range for this stock, meaning implied volatility offers neither a clear selling edge nor a bargain. Directional conviction matters more than vol here.

For what this number does and does not tell you about WST's options, see IV Rank explained.

WEST PHARMACEUTICAL SERVICES INC (WST) next earnings date — 2026-10-29

WEST PHARMACEUTICAL SERVICES INC (WST) reports earnings on 2026-10-29 — about 8 days away, which falls inside a typical options expiry window. WST's IV Rank is currently 62. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer